Cointime

Avaxia Biologics

company

About

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform.

  • 11 - 50

Highlights

Total Funding Amount
$22M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
$6.40M
Industries
Biotechnology,Medical Device,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity.

Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$22M
Avaxia Biologics has raised a total of $22M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2013 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2013 Series B $11.50M 2 — — Detail
Dec 19, 2012 Series B $6.40M 3 — — Detail
Feb 14, 2012 Series A $4.10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Avaxia Biologics is funded by 3 investors. Granite State Angels and North Country Angels are the most recent investors.
Investor Name Lead Investor Funding Round
Granite State Angels — Series B
North Country Angels — Series B
Keiretsu Forum — Series B
Cointime
Chủ Đề
Công Ty